5
Participants
Start Date
June 5, 2018
Primary Completion Date
October 16, 2020
Study Completion Date
August 25, 2021
Exenatide
Exenatide will be administered through a subcutaneous injection once per week for the duration of the study (1 year).
Laboratory for Rehabilitation Neuroscience, Gainesville
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of Florida
OTHER